Tidelands Health

Tidelands Health
4181 Highway 17 Bypass
Murrells Inlet, SC 29576

Barbara Roe, Research Coordinator: broe@tidelandshealth.org

National Cancer Institute Community Oncology Research Program logo

As an affiliate of the Medical University of South Carolina, Tidelands Health is an active Minority/Underserved NCORP site. Tidelands Health is currently active on the following clinical trials addressing various cancer types. Ask your health care provider for more information.

All Disease Sites

  • A222004: Olanzapine versus Megestrol Acetate for the treatment of loss of appetite among cancer patients
    This trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that has spread to other places in the body (advanced).
    Trial Details
  • WF-1901: An Internet-based Program to Help Cancer Survivors Manage Pain
    This trial compares the effect of adding an internet-based pain program (painTRAINER) to enhanced usual care versus enhanced usual care alone in improving pain severity and pain interference in cancer survivors.
    Trial Details
  • S1912CD: A Randomized Trial Addressing Cancer-Related Financial Hardship Through Delivery of a Proactive Financial Navigation Intervention (CREDIT)
    This trial examines a financial navigation program in helping patients and their spouses understand and better manage the financial aspects of cancer care.
    Trial Details
  • URCC-21038: An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study (Pending Activation)
    This study compares treatment outcomes between patients of African American/Black (AA) ancestry and European American/White (EA) ancestry currently receiving immune checkpoint inhibitor treatment.
    Trial Details


  • A011202: Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy (Temporarily Suspended)
    This trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast cancer previously treated with chemotherapy and surgery.
    Trial Details
  • BR007: Testing the usual treatment of radiation therapy and hormonal therapy to hormonal therapy alone for low-risk, early stage breast cancer
    This trial compares the effect of radiation therapy combined with hormonal therapy versus hormonal therapy alone in treating patients with low risk, early stage breast cancer with Oncotype Dx Recurrence less than 18.
    Trial Details


  • A021703: Testing the addition of high-dose vitamin D3 to usual chemotherapy treatment and bevacizumab for untreated advanced colorectal cancer
    This trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body (advanced or metastatic).
    Trial Details
  • A221805: Duloxetine to prevent oxaliplatin-induced peripheral neuropathy
    This trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, numbness and muscle weakness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer.
    Trial Details
  • EA2185: Comparing Two Methods to Follow Patients with Pancreatic Cysts
    The purpose of this study is to compare more frequent monitoring vs less frequent monitoring in order to learn which monitoring method leads to better outcome for patients with pancreatic cysts.
    Trial Details
  • EA2186: Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients with Pancreatic Cancer that has Spread
    This trial compares two treatment combinations: gemcitabine hydrochloride and nab-paclitaxel, or fluorouracil, leucovorin calcium, and liposomal irinotecan in older patients with pancreatic cancer that has spread to other places in the body (metastatic).
    Trial Details

Malignant Hematology

  • EAA171: Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients with Evidence of Residual Multiple Myeloma
    This trial studies how well lenalidomide in combination with ixazomib works compared to lenalidomide alone in treating patients with evidence of residual multiple myeloma after stem cell transplantation.
    Trial Details


  • EA6174: Testing Pembrolizumab versus Observation in Patients with Merkel Cell Carcinoma after Surgery
    This trial studies how well pembrolizumab works compared to standard of care observation in treating patients with stage I-III Merkel cell cancer that has been completely removed by surgery (resected).
    Trial Details


  • A171901: Testing the effects of MK-3475 (pembrolizumab) with or without the usual chemotherapy treatment for patients 70 years of age and older with advanced non-small cell lung cancer
    This trial studies the side effects of pembrolizumab with or without chemotherapy in treating patients with stage IV non-small cell lung cancer that has come back (recurrent) and has spread to other places in the body (advanced).
    Trial Details
  • EA5163: Testing the timing of immunotherapy alone or with chemotherapy as first line treatment and maintenance in non-small cell lung cancer
    This trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression, is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer.
    Trial Details